by rss feed | May 31, 2026 | LDL gene editing, News Feeds, Verve Therapeutics
If you take a statin to improve your lipid profile, someday could you undergo LDL gene editing instead? Might that day be sooner than we think? A new paper has generated great interest in this topic including in the media. LDL gene editing For example, we have:...
by rss feed | May 25, 2025 | CRISPR therapy, Editas, News Feeds, Verve Therapeutics, weekly reads
There has been a sizable downturn for the CRISPR therapy biotech arena. Firms like Editas, Verve, Intellia, and even CRISPR Therapeutics, which has garnered an FDA approval, have had struggles recently. It feels like a disconnect here in a way because overall gene...
by rss feed | Nov 19, 2023 | Casgevy, CRISPR, News Feeds, Verve Therapeutics, weekly reads
Some folks can view data from early, small clinical trials too skeptically or overly enthusiastically, and maybe that’s going on with some preliminary results from Verve Therapeutics. Good news? Bad news? I’m going to start with two articles about the same...
